Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment
Clinical trial NCT04169841 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04169841
- Sponsor
- Centre Georges Francois Leclerc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2027-08-10
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.